Postconditioning with Simvastatin Decreases Myocardial Injury in Rats Following Acute Myocardial Ischemia

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2015 Mar 18

PMID 25780404

Citations 5

Authors

Heng-Chen Yao

Lan-Ju Yang

Qian-Feng Han

Lan-Hua Wang

Lei Wu

Chun-Yan Zhang

Ke-Li Tian

Mei Zhang

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate whether postconditioning with simvastatin attenuated myocardial ischemia reperfusion injury by inhibiting the expression of high mobility group box 1 (HMGB1) in rat myocardium following acute myocardial ischemia. In total, 30 male Sprague-Dawley rats were divided into sham operation (sham; n=10), acute myocardial infarction (AMI; n=10) and simvastatin (sim; n=10) groups. The AMI and sim groups were subjected to ischemia for 30 min, followed by reperfusion for 180 min. The rats in the sim group were administered 20 mg/kg simvastatin intravenously 5 min prior to reperfusion. Subsequently, the infarct size, serum cardiac troponin (c-TnI), tumor necrosis factor (TNF)-α and myocardial malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity were measured. Western blot analysis was used to detect the protein expression of HMGB1. Postconditioning with simvastatin was shown to decrease the infarct size and HMGB1 expression levels in the myocardium following AMI (P<0.05). In addition, postconditioning with simvastatin not only decreased the serum levels of c-TnI and TNF-α (P<0.05), but also inhibited the increase in MDA levels and the reduction in SOD activity (P<0.05). Therefore, postconditioning with simvastatin was shown to attenuate myocardial injury. The underlying mechanism may be associated with the downregulation of HMGB1 expression in the ischemic myocardium.

Citing Articles

HMGB1 Protects the Heart Against Ischemia-Reperfusion Injury via PI3K/AkT Pathway-Mediated Upregulation of VEGF Expression.

Zhou Y, Han Q, Gao L, Sun Y, Tang Z, Wang M Front Physiol. 2020; 10:1595.

PMID: 32063860 PMC: 7000523. DOI: 10.3389/fphys.2019.01595.

High mobility group box 1 protein attenuates myocardial ischemia reperfusion injury via inhibition of the p38 mitogen-activated protein kinase signaling pathway.

Zhou Y, Han Q, Wang L, Liu T, Meng X, Wu L Exp Ther Med. 2017; 14(2):1582-1588.

PMID: 28810624 PMC: 5525636. DOI: 10.3892/etm.2017.4653.

Simvastatin attenuates chromium-induced nephrotoxicity in rats.

Goodarzi Z, Karami E, Ahmadizadeh M J Nephropathol. 2017; 6(1):5-9.

PMID: 28042547 PMC: 5106881. DOI: 10.15171/jnp.2017.02.

Intravenous high mobility group box 1 upregulates the expression of HIF-1α in the myocardium via a protein kinase B-dependent pathway in rats following acute myocardial ischemia.

Yao H, Zhou M, Zhou Y, Wang L, Zhang D, Han Q Mol Med Rep. 2015; 13(2):1211-9.

PMID: 26648172 PMC: 4732844. DOI: 10.3892/mmr.2015.4648.

Erythropoietin pretreatment suppresses inflammation by activating the PI3K/Akt signaling pathway in myocardial ischemia-reperfusion injury.

Rong R, Xijun X Exp Ther Med. 2015; 10(2):413-418.

PMID: 26622330 PMC: 4509423. DOI: 10.3892/etm.2015.2534.

References

Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A . Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003; 22(20):5551-60. PMC: 213771. DOI: 10.1093/emboj/cdg516. View

Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R . Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res. 2006; 100(1):140-6. DOI: 10.1161/01.RES.0000255031.15793.86. View

Andrassy M, Volz H, Riedle N, Gitsioudis G, Seidel C, Laohachewin D . HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med. 2011; 270(3):245-53. DOI: 10.1111/j.1365-2796.2011.02369.x. View

Li X, Yang Y, Geng Y, Cheng Y, Zhang H, Zhao J . The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway. Int J Cardiol. 2012; 167(6):2657-66. DOI: 10.1016/j.ijcard.2012.06.121. View

Ding H, Yang J, Chen P, Yang J, Bo S, Ding J . The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis. Gene. 2013; 527(1):389-93. DOI: 10.1016/j.gene.2013.05.041. View

Yao H, Zhao A, Han Q, Wu L, Yao D, Wang L . Correlation between serum high-mobility group box-1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease. Exp Ther Med. 2013; 6(1):121-124. PMC: 3735905. DOI: 10.3892/etm.2013.1095. View

Oozawa S, Mori S, Kanke T, Takahashi H, Liu K, Tomono Y . Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ J. 2008; 72(7):1178-84. DOI: 10.1253/circj.72.1178. View

Hu X, Zhou X, He B, Xu C, Wu L, Cui B . Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur J Pharmacol. 2010; 638(1-3):84-9. DOI: 10.1016/j.ejphar.2010.03.059. View

Jiang X, Ai C, Shi E, Nakajima Y, Ma H . Neuroprotection against spinal cord ischemia-reperfusion injury induced by different ischemic postconditioning methods: roles of phosphatidylinositol 3-kinase-Akt and extracellular signal-regulated kinase. Anesthesiology. 2009; 111(6):1197-205. DOI: 10.1097/ALN.0b013e3181bf1d93. View

10.

Leng Y, Zhang Y, Xue X, Wang T, Kang Y . Ischemic post-conditioning attenuates the intestinal injury induced by limb ischemia/reperfusion in rats. Braz J Med Biol Res. 2011; 44(5):411-7. DOI: 10.1590/S0100-879X2011007500045. View

11.

Lakhan S, Kirchgessner A, Hofer M . Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med. 2009; 7:97. PMC: 2780998. DOI: 10.1186/1479-5876-7-97. View

12.

Braunwald E, Kloner R . Myocardial reperfusion: a double-edged sword?. J Clin Invest. 1985; 76(5):1713-9. PMC: 424191. DOI: 10.1172/JCI112160. View

13.

Ke D, Fang J, Fan L, Chen Z, Chen L . Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury. Coron Artery Dis. 2013; 24(4):334-41. DOI: 10.1097/MCA.0b013e3283608c12. View

14.

Yao H, Liu T, Meng X, Han Q, Zhang M, Wang L . Effect of basic fibroblast growth factor on the myocardial expression of hypoxia-inducible factor-1α and vascular endothelial growth factor following acute myocardial infarction. Heart Lung Circ. 2013; 22(11):946-51. DOI: 10.1016/j.hlc.2013.04.111. View

15.

Tsung A, Klune J, Zhang X, Jeyabalan G, Cao Z, Peng X . HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007; 204(12):2913-23. PMC: 2118528. DOI: 10.1084/jem.20070247. View

16.

Cao Q, Qu M, Yang W, Wang D, Zhang M, Di S . Ischemia postconditioning preventing lung ischemia-reperfusion injury. Gene. 2014; 554(1):120-4. DOI: 10.1016/j.gene.2014.10.009. View

17.

Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H . Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat. Transpl Int. 2007; 21(4):364-71. DOI: 10.1111/j.1432-2277.2007.00606.x. View

18.

Ren D, Sun R, Wang S . Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box 1--induced acute lung injury. Inflamm Res. 2006; 55(5):207-15. DOI: 10.1007/s00011-006-0072-2. View

19.

Eltzschig H, Eckle T . Ischemia and reperfusion--from mechanism to translation. Nat Med. 2011; 17(11):1391-401. PMC: 3886192. DOI: 10.1038/nm.2507. View

20.

Kong Y, Rogers M, Qin X . Effective neuroprotection by ischemic postconditioning is associated with a decreased expression of RGMa and inflammation mediators in ischemic rats. Neurochem Res. 2013; 38(4):815-25. DOI: 10.1007/s11064-013-0984-5. View